Skip to main content
. 2022 Oct 17;12:1023219. doi: 10.3389/fcimb.2022.1023219

Table 3.

Limit of detection (LoD) for nine rapid diagnostic tests.

Rapid Diagnostic Test In vitro Limit of DetectionParasites/µL [95% CI] Lowest recorded positive result (Parasites/µL)
PkA1-H.1 culture isolate*# Pf3D7 culture isolate¥ P. knowlesi clinical sample°
Pan-pLDH Pan-pLDH HRP2 Pan-pLDH
First Response 98.03
[89.66 - 106.40]
98.09
[89.68-106.49]
<7.8
[n/a]
50
CareStart™ PAN 24.63
[18.20 - 31.05]
49.18
[41.75-56.62]
n/a 50
STANDARD Q 195.61
[186.26-204.97]
778.73
[767.39-790.09]
24.67
[18.21-31.13]
40
CareStart™ combo 98.03
[89.66 - 106.40]
195.69
[186.29-205.08]
12.39
[6.90-17.87]
50
Parascreen® 195.61
[186.26 - 204.97]
195.69
[186.29-205.08]
<7.8
[n/a]
50
One Step test MERISCREEN 1555.14
[1543.24 - 1567.05]
390.48
[380.08-400.89]
24.67
[18.21-31.13]
SD BIOLINE >2000
[n/a]
1556.54
[1544.88-1568.19]
12.39
[6.90-17.87]
254
Pv-pLDH Pf-pLDH Pf-HRP2 Pv-pLDH
Biocredit™ 49.18
[41.75 - 56.62]
49.18
[41.75-56.62]
n/a 40
FalciVax 49.18
[41.75 - 56.62]
n/a 12.39
[6.90-17.87]
50

*No P. falciparum-HRP2 bands were detected with the Pk A1-H.1 culture isolate for any of the RDTs screened (i.e., no cross-reactivity).

#No P. falciparum bands were detected with the Pk A1-H.1 culture isolate for either of the RDTs screened, but cross reactivity was observed with P. vivax lines.

¥No P. vivax lines were detected with the Pf3D7 culture isolate (i.e., no cross-reactivity).

° Includes patients tested before antimalarial treatment only.

n/a, Not Applicable.